R&D
Partner Content
Viral Vector Process Development & Manufacturing Summit Returns to Boston!
With the FDA’s fast-evolving quality assessment and lack of standard …
19752 items found
Digital
Five healthtech trends to watch in 2024
The 10,000-foot view of healthtech is typically optimistic. …
R&D
Understanding the impact of AI on the advancement of gene therapy development
The biopharmaceutical landscape stands at the cusp of a …
Digital
Market Access
Illumina-Grail saga ends with divestment
In a case that had been closely watched across multiple industries, …
News
Sun Pharma reaches deal to buy out Taro in $347m deal
India’s Sun Pharma has signed an agreement to take full control of …
News
FDA clears AI skin cancer detection device from DermaSensor
Medtech company DermaSensor has claimed FDA approval for a handheld …
News
Bayer reaches deal on shedding management layers
After lengthy negotiations, Bayer has reached a deal with union …
Patients
Sponsored
How post-fracture care programmes such as fracture liaison services can bridge the treatment gap for osteoporosis
As society globally faces a growing elderly population, age-related …
News
Winners named in NHS healthcare inequality contest
A competition aimed at tackling unequal access to healthcare in the …
News
Ban on Apple Watches with pulse oximetry renews in US
Apple has once again been prevented from selling two of its Apple …
Digital
How new technologies help keep brand planning simple
Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, says …
News
Novartis gets FDA okay for frontline use of Scemblix in CML
Novartis has picked up a new FDA approval for its chronic myeloid leukaemia therapy Scemblix that it believes is critical to unlocking the drug's blockbuster sales potential.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
